Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP715780.RAVW-Cplb7cHNpMAX8mniR6EF-eg_dEECv5aL6nukM-JA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP715780.RAVW-Cplb7cHNpMAX8mniR6EF-eg_dEECv5aL6nukM-JA130_assertion type Assertion NP715780.RAVW-Cplb7cHNpMAX8mniR6EF-eg_dEECv5aL6nukM-JA130_head.
- NP715780.RAVW-Cplb7cHNpMAX8mniR6EF-eg_dEECv5aL6nukM-JA130_assertion description "[To investigate the molecular basis of an experimental combination therapy for malignant gliomas with TRAIL and Troglitazone, we investigated the Troglitazone-induced signaling cascades and the expression of TRAIL receptors and FLIP in malignant gliomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP715780.RAVW-Cplb7cHNpMAX8mniR6EF-eg_dEECv5aL6nukM-JA130_provenance.
- NP715780.RAVW-Cplb7cHNpMAX8mniR6EF-eg_dEECv5aL6nukM-JA130_assertion evidence source_evidence_literature NP715780.RAVW-Cplb7cHNpMAX8mniR6EF-eg_dEECv5aL6nukM-JA130_provenance.
- NP715780.RAVW-Cplb7cHNpMAX8mniR6EF-eg_dEECv5aL6nukM-JA130_assertion SIO_000772 19158480 NP715780.RAVW-Cplb7cHNpMAX8mniR6EF-eg_dEECv5aL6nukM-JA130_provenance.
- NP715780.RAVW-Cplb7cHNpMAX8mniR6EF-eg_dEECv5aL6nukM-JA130_assertion wasDerivedFrom befree-2016 NP715780.RAVW-Cplb7cHNpMAX8mniR6EF-eg_dEECv5aL6nukM-JA130_provenance.
- NP715780.RAVW-Cplb7cHNpMAX8mniR6EF-eg_dEECv5aL6nukM-JA130_assertion wasGeneratedBy ECO_0000203 NP715780.RAVW-Cplb7cHNpMAX8mniR6EF-eg_dEECv5aL6nukM-JA130_provenance.